home / stock / bfra / bfra news

BFRA News and Press, Biofrontera AG From 02/26/20

Stock Information
Company Name: Biofrontera AG
Stock Symbol: BFRA
Market: NASDAQ
Menu
BFRA BFRA Quote BFRA Short BFRA News BFRA Articles BFRA Message Board
Get BFRA Alerts

News, Short Squeeze, Breakout and More Instantly...
BFRA - Biofrontera AG resolves to issue qualified subordinated mandatory convertible bonds

Leverkusen, Germany, Feb. 26, 2020 (GLOBE NEWSWIRE) -- The Executive Board of Biofrontera AG (NASDAQ ticker symbol: BFRA, ISIN: DE0006046113), today resolved, with the approval of the Supervisory Board, to issue two qualified subordinated mandatory convertible bonds. The following are to...
BFRA - Biofrontera provides clinical development updates

Leverkusen, Germany, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today provides an update on its clinical developments. On February 3, 2020, the Company announc...

BFRA - European advisory group backs expanded label for Biofrontera's Ameluz

The European Medicines Agency's advisory group CHMP has issued a positive opinion with respect to Biofrontera AG's (NASDAQ: BFRA ) submission for label extension for its topical prescription drug Ameluz. More news on: Biofrontera AG, Healthcare stocks news, Read more ...

BFRA - European Medicines Agency recommends indication expansion of Ameluz® for treatment of actinic keratoses on the extremities and trunk/neck

Leverkusen, Germany, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medic...
BFRA - Organizational restructuring of Biofrontera and resignation of Chief Commercial Officer Christoph Dünwald

Leverkusen, Germany, Jan. 31, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that it has reorganized its European sales structure. The operational change was p...

BFRA - Biofrontera announces 1-year follow-up results for its phase III study of photodynamic therapy for actinic keratosis on the extremities and trunk/neck

Leverkusen, Germany, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced follow-up results for its Phase III clinical study evaluating the safety and efficac...

BFRA - Biofrontera reports preliminary Q4 and FY 2019 sales

Biofrontera AG (NASDAQ: BFRA ) reports preliminary Q4 and FY 2019 results. More news on: Biofrontera AG, Healthcare stocks news, Read more ...

BFRA - Biofrontera announces preliminary sales figures for the full year 2019, record sales in the 4th quarter

Leverkusen, Germany, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its results for the first nine months ended September 30, 2019. At the same time, th...

BFRA - Biofrontera strengthens commercial focus with reorganization of its US business

Leverkusen, Germany, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced a new organizational structure of its American subsidiary Biofrontera Inc. to streng...

BFRA - Extraordinary General Meeting of Biofrontera AG: Biofrontera Management Board supported by large majority

Leverkusen, Germany, Dec. 20, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced the results of the Extraordinary General Meeting held on December 19, 2019. The shar...
Previous 10 Next 10